IFNG and Alzheimer disease: IL-33, in turn, has its production stimulated in keratinocytes via MAPK through positive feedback by cytokines produced by dermal inflammatory cells in AD, such as Th1 (via interferon-gamma production), Th17 (via IL-17) and Th2 (via IL-4 and IL-13).